September 18, 2008

The Food and Drug Administration issued a warning to the Republic of Indiana regarding drugs from Ranbaxy Laboratories, Ltd. due to noncompliance with FDA standards which could lead to drug injuries.

The warning comes after the FDA became concerned with U.S. current Good Manufacturing Practices at the plant which produces generic drugs.

Drugs not approved by the FDA could cause Texas drug injuries to patients.

Read more